Aeterna Zentaris (AEZS) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free AEZS Stock Alerts C$2.65 -0.01 (-0.38%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAEterna Zentaris: Top 25 Undervalued Toronto Stock Exchange Stocks (AEZS)theglobeandmail.com - March 31 at 10:16 PMCourt Approves Ceapro-Aeterna Merger - Quick Factsmarkets.businessinsider.com - March 28 at 2:57 PMCeapro Receives Final Court Approval for Merger with Aeterna Zentarisfinance.yahoo.com - March 28 at 7:56 AMAEterna Zentaris Stock (NASDAQ:AEZS) Dividends: History, Yield and Datesbenzinga.com - February 21 at 7:41 PMAeterna Zentaris files to sell 2.53M warrantsmsn.com - February 15 at 6:42 PMAeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceaprofinance.yahoo.com - February 15 at 6:42 PMClosing Bell: Aeterna Zentaris Inc flat on Monday (AEZS)theglobeandmail.com - January 22 at 6:23 PMAEZS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aeterna Zentaris Inc. Is Fair to Shareholderstmcnet.com - December 14 at 2:07 PMAeterna Zentaris, Ceapro to Combinemarketwatch.com - December 14 at 9:07 AMCanadian Investment Regulatory Organization Trade Resumption - AEZSca.finance.yahoo.com - December 14 at 9:07 AMAeterna Zentaris Enters Into Merger Agreement With Ceapromarkets.businessinsider.com - December 14 at 9:07 AMAeterna Zentaris and Ceapro to merge in all-stock dealmsn.com - December 14 at 9:07 AMAEterna Zentaris: Top 10 Undervalued Growth Stocks on TSX (AEZS)theglobeandmail.com - October 20 at 9:56 AMAeterna Zentaris Inc: Aeterna Zentaris Reports Second Quarter 2023 Financial Resultsfinanznachrichten.de - August 9 at 1:42 PMAeterna Zentaris Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 9 at 8:41 AMAnalysts Offer Insights on Healthcare Companies: Aeterna Zentaris (AEZS) and Alnylam Pharma (ALNY)markets.businessinsider.com - July 14 at 8:45 AMAeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Seriesfinance.yahoo.com - July 5 at 9:32 AMAeterna Zentaris Announces Results of Virtual 2023 Meeting of Shareholdersfinance.yahoo.com - June 14 at 5:44 PMClosing Bell: Aeterna Zentaris Inc down on Thursday (AEZS)theglobeandmail.com - May 25 at 7:47 PMClosing Bell: Aeterna Zentaris Inc up on Tuesday (AEZS)theglobeandmail.com - May 24 at 12:32 AMClosing Bell: Aeterna Zentaris Inc up on Friday (AEZS)theglobeandmail.com - May 5 at 6:04 PMSpeculative Money Propels Biotechs La Jolla Pharma, Aeterna Zentaristhestreet.com - April 21 at 7:51 AMAnalysts Offer Insights on Healthcare Companies: Timber Pharmaceuticals (TMBR), Aeterna Zentaris (AEZS) and Cabaletta Bio (CABA)markets.businessinsider.com - April 10 at 9:28 AMAnalysts Have Conflicting Sentiments on These Healthcare Companies: Aeterna Zentaris (AEZS), Delcath Systems (DCTH) and GlaxoSmithKline (GSK)markets.businessinsider.com - March 28 at 8:00 AMAeterna Zentaris Inc: Aeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial Resultsfinanznachrichten.de - March 23 at 10:07 AMPharmanovia to Market GHRYVELIN(TM) (Macimorelin) in the European Economic Area (EEA) and UK as Diagnostic Test for Growth Hormone Deficiency (GHD)stockhouse.com - March 18 at 1:51 PMAeterna Zentaris Inc. (AEZS.TO)ca.finance.yahoo.com - February 17 at 1:15 PMAEterna Zentaris Stock Gaps Down On Today's Open (AEZS)thestreet.com - January 11 at 3:27 PMAEterna Zentaris Stock (NASDAQ:AEZS), Quotes and News Summarybenzinga.com - January 5 at 2:56 PMAEterna Zentaris: Q3 Earnings Insightsmsn.com - November 3 at 10:56 AMAeterna Zentaris Inc. (AEZS)finance.yahoo.com - September 25 at 12:59 AMAeterna Zentaris Increuters.com - September 14 at 11:03 PMAeterna Zentaris Set to Regain Full Rights to Macrilen(TM) (Macimorelin) in U.S. and Canada from Novo Nordiskstockhouse.com - August 30 at 6:35 PMAeterna Zentaris Inc stock eased on Friday.theglobeandmail.com - August 2 at 1:56 PMAeterna Zentaris Inc: Aeterna Zentaris Announces Shareholder Approval of Share Consolidationfinanznachrichten.de - July 18 at 10:41 AMAeterna Zentaris Announces Shareholder Approval of Share Consolidationfinance.yahoo.com - July 15 at 8:20 PMAeterna Zentaris Announces Further Adjournment of Shareholder Meetingfinance.yahoo.com - July 6 at 8:59 PMAeterna Zentaris Announces Results of Annual Meeting of Shareholdersfinance.yahoo.com - June 21 at 4:21 PMAeterna Zentaris Achieves Proof-of-Concept for the Treatment of NMOSD with AIM Biologicals Programfinance.yahoo.com - June 13 at 12:09 PMHere's Why We're Watching Aeterna Zentaris' (TSE:AEZS) Cash Burn Situationfinance.yahoo.com - June 3 at 7:28 AMAeterna Zentaris’ Licensing Partner, Consilient Health Announces European Launch of Ghryvelin™ (macimorelin) for Diagnosing Adult Growth Hormone Deficiencyfinance.yahoo.com - May 25 at 8:12 AMAeterna Zentaris to Present at the H.C. Wainwright Global Investment Conferencefinance.yahoo.com - May 18 at 8:36 AMAeterna Zentaris Announces Virtual 2022 Meeting of Shareholders and Urges Shareholders to Vote in Favor of the Proposed Share Consolidationfinance.yahoo.com - May 16 at 8:38 AMGranite Point Mortgage Trust Inc. Announces $590 million Refinancing of Legacy Funding Vehicles, Incremental $50 million Repayment of Term Loan Borrowings and Preliminary Financial Results for First Quarter 2022finance.yahoo.com - April 28 at 7:26 PMAeterna Zentaris to Participate at the Virtual Investor 2022 CEO Spotlightfinance.yahoo.com - April 12 at 8:13 AMAeterna Zentaris Provides Update on Ongoing Pivotal Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiencyfinance.yahoo.com - March 21 at 9:08 AMAeterna Zentaris to get US patent for potential hormone disorder therapy AEZS-150seekingalpha.com - March 2 at 2:33 PMAeterna Zentaris Announces Notice of Allowance for U.S. Patent Covering AEZS-150 for the Potential Treatment of Chronic Hypoparathyroidismfinance.yahoo.com - March 2 at 9:29 AMAeterna Zentaris to Present at the 2022 BIO CEO & Investor Conferencefinance.yahoo.com - February 7 at 9:22 AMLegacy Financial Advisors, Inc. Buys iShares Core U.S. ...finance.yahoo.com - February 4 at 3:07 PM Get Aeterna Zentaris News Delivered to You Automatically Sign up to receive the latest news and ratings for AEZS and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. AEZS Media Mentions By Week AEZS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AEZS News Sentiment▼0.000.32▲Average Medical News Sentiment AEZS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AEZS Articles This Week▼00▲AEZS Articles Average Week Get Aeterna Zentaris News Delivered to You Automatically Sign up to receive the latest news and ratings for AEZS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IMV News Today Antibe Therapeutics News Today Resverlogix News Today Sirona Biochem News Today Kane Biotech News Today Ceapro News Today Quest PharmaTech News Today Innovotech News Today Hemostemix News Today Aptose Biosciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:AEZS) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aeterna Zentaris Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
